ADARx Pharmaceuticals, Inc. (ADRX) SEC filings
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.20−0.71 (-4.76%)
Close on Nov 13, 2026Market cap $1.52BP/E –Yield –
SEC filings
3 of ADARx Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |
See a number that looks wrong?